0001019687-11-002030.txt : 20110622 0001019687-11-002030.hdr.sgml : 20110622 20110622142135 ACCESSION NUMBER: 0001019687-11-002030 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110622 ITEM INFORMATION: Regulation FD Disclosure FILED AS OF DATE: 20110622 DATE AS OF CHANGE: 20110622 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AETHLON MEDICAL INC CENTRAL INDEX KEY: 0000882291 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 133632859 STATE OF INCORPORATION: NV FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-21846 FILM NUMBER: 11925416 BUSINESS ADDRESS: STREET 1: 8910 UNIVERSITY CENTER LANE, SUITE 660 CITY: SAN DIEGO STATE: CA ZIP: 92122 BUSINESS PHONE: 858-459-7800 MAIL ADDRESS: STREET 1: 8910 UNIVERSITY CENTER LANE, SUITE 660 CITY: SAN DIEGO STATE: CA ZIP: 92122 FORMER COMPANY: FORMER CONFORMED NAME: BISHOP EQUITIES INC DATE OF NAME CHANGE: 19930602 8-K 1 aethlon_8k-062211.htm CURRENT REPORT ON FORM 8-K aethlon_8k-062211.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported):  June 22, 2011
  
     
AETHLON MEDICAL, INC.
(Exact name of registrant as specified in its charter)
 
Nevada
(State or other jurisdiction of incorporation)
000-21846
(Commission File Number)
13-3632859
(I.R.S. Employer Identification No.)
 
8910 University Center Lane, Suite 660
San Diego, California
(Address of principal executive offices)
 
92122
(Zip Code)
 
Registrant’s telephone number, including area code:  (858) 459-7800
 
Not Applicable
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 

 
 
 
 
 
Item 7.01Regulation FD Disclosure
 
 
The Registrant disclosed that on Wednesday, June 22, 2011, it made a presentation at the RedChip Small-Cap Equities Virtual Conference VIII.  A copy of the presentation materials was made available on the Registrant’s website (www.aethlonmedical.com) under the Events and Presentation section of the Investor Relations page today, June 22, 2011.

  
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
  
 
AETHLON MEDICAL, INC.
 
(Registrant)
 
 
 
 
 
 
Date: June 22, 2011
By:
/s/ James B. Frakes
 
 
James B. Frakes
 
 
Chief Financial Officer